trial · primary record
Bevacizumab
Advanced Endometrial Carcinoma
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 255 |
| Primary completion | 2028-07-01 |
| Primary endpoint | Progression-free survival (PFS) |
| Registry ID | NCT07198074 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:23.769Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07198074
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Bevacizumab · compound